Document is current
Any future updates will be listed below
-
Authors
Sawyer, Chelsea S.
Taylor, Sally
Carter, Louise
Stanworth, Melissa
Davies, Michelle
Thistlethwaite, Fiona
Taylor, Jo
Eastwood, Charlotte
Yorke, Janelle
-
Funding
Funding for this research was provided by:
Manchester Experimental Cancer Medicine Centres (ECMC) and The Christie CRF Charity
- License Information
-
More Information
Article History
Received: 13 January 2023
Accepted: 5 February 2024
First Online: 19 April 2024
Declarations
:
: <b>E</b>thical approval for the study was provided by the National Research Ethics Committee, South Central Oxford B (18/SC/0299), and the local NHS Trusts. The study was carried out in accordance with relevant guidelines and regulations and written informed consent was gained from all participants.
: Not applicable.
: The authors declare no competing interests.
: Our Patient and Public Involvement (PPI) team was comprised of a patient advocate, as well as dedicated members from the experimental cancer medicine team and nursing staff. The PPI team were involved throughout the entire questionnaire development process, including reviewing interview schedules for Stage 1, evaluating potential interview questions, and offering valuable feedback. Minor refinements in wording and item sequencing were carried out as suggested by the PPI team. Furthermore, the PPI team actively contributed to the preparation of this manuscript.
